Forward Pharma A/S News Releases http://ir.forward-pharma.com/ Forward Pharma A/S News Releases en Forward Pharma Reports Financial and Operational Results from the Year Ended December 31, 2018 http://ir.forward-pharma.com/news-releases/news-release-details/forward-pharma-reports-financial-and-operational-results-year COPENHAGEN, Denmark , April 04, 2019 (GLOBE NEWSWIRE) -- Forward Pharma A/S (NASDAQ:FWP) (“We,” “Forward” or the “Company” and, together with its subsidiaries, the “Group”), today reported consolidated financial results for the year ended December 31, 2018 . Thu, 04 Apr 2019 16:30:00 -0400 Forward Pharma A/S News Releases 7866 Forward Pharma to Participate in the DKBIO2019 Life Science Investor Conference http://ir.forward-pharma.com/news-releases/news-release-details/forward-pharma-participate-dkbio2019-life-science-investor-0 COPENHAGEN, Denmark , March 27, 2019 (GLOBE NEWSWIRE) -- Forward Pharma A/S  (NASDAQ:FWP) (the “Company”) today announced that Dr. Claus Bo Svendsen, the Company’s Chief Executive Officer, will participate in the DKBIO2019 life science investor conference in New York, NY . Dr. Wed, 27 Mar 2019 08:30:29 -0400 Forward Pharma A/S News Releases 7856 Forward Pharma to Participate in the DKBIO2019 Life Science Investor Conference http://ir.forward-pharma.com/news-releases/news-release-details/forward-pharma-participate-dkbio2019-life-science-investor COPENHAGEN, Denmark , March 27, 2019 (GLOBE NEWSWIRE) -- Forward Pharma A/S  (NASDAQ:FWP) (the “Company”) today announced that Dr. Claus Bo Svendsen, the Company’s Chief Executive Officer, will participate in the DKBIO2019 life science investor conference in New York, NY . Dr. Wed, 27 Mar 2019 08:30:00 -0400 Forward Pharma A/S News Releases 7851 Forward Pharma Provides Update on the Decision of the Federal Circuit in its Appeal of the U.S. Patent Interference http://ir.forward-pharma.com/news-releases/news-release-details/forward-pharma-provides-update-decision-federal-circuit-its The U.S. Court of Appeals for the Federal Circuit has affirmed the decision of the Patent Trial and Appeal Board in the U.S. patent interference proceeding The appeal of the European EP2801355 patent opposition continues Forward expects to reduce operating expenses to match the current situation Wed, 24 Oct 2018 10:42:25 -0400 Forward Pharma A/S News Releases 7781 Forward Pharma to Participate in the Ladenburg Thalmann 2018 Healthcare Conference http://ir.forward-pharma.com/news-releases/news-release-details/forward-pharma-participate-ladenburg-thalmann-2018-healthcare COPENHAGEN, Denmark , Sept. 28, 2018 (GLOBE NEWSWIRE) -- Forward Pharma A/S  (NASDAQ:FWP) (the “Company”) today announced that Dr. Claus Bo Svendsen, the Company’s Chief Executive Officer, will participate in the Ladenburg Thalmann 2018 Healthcare Conference in New York, NY . Dr. Fri, 28 Sep 2018 07:30:58 -0400 Forward Pharma A/S News Releases 7776 Forward Pharma Reports Financial and Operational Results from the First Six Months of 2018 http://ir.forward-pharma.com/news-releases/news-release-details/forward-pharma-reports-financial-and-operational-results-first-0 COPENHAGEN, Denmark , Sept. 19, 2018 (GLOBE NEWSWIRE) -- Forward Pharma A/S (NASDAQ:FWP) (“We”, “Forward” or the “Company” and together with its subsidiaries, the “Group”), today reported consolidated financial results for the six-month period ended June 30, 2018 . Wed, 19 Sep 2018 16:20:50 -0400 Forward Pharma A/S News Releases 7771 Forward Pharma to Participate in the LSX Nordic Congress http://ir.forward-pharma.com/news-releases/news-release-details/forward-pharma-participate-lsx-nordic-congress COPENHAGEN, Denmark , Aug. 23, 2018 (GLOBE NEWSWIRE) -- Forward Pharma A/S (NASDAQ:FWP) (the “Company”) today announced that Dr. Claus Bo Svendsen , the Company’s Chief Executive Officer, will participate in the LSX Nordic Congress being held August 29-30, 2018 in Stockholm, Sweden . Dr. Thu, 23 Aug 2018 08:01:01 -0400 Forward Pharma A/S News Releases 7766 Forward Pharma Appeals the Decision of the Opposition Division to Revoke the EP2801355 Patent http://ir.forward-pharma.com/news-releases/news-release-details/forward-pharma-appeals-decision-opposition-division-revoke COPENHAGEN, Denmark , May 07, 2018 (GLOBE NEWSWIRE) -- Forward Pharma A/S (Nasdaq:FWP) (“We” or “Forward” or the “Company”), today announced the filing of a notice of appeal of the decision of the Opposition Division of the European Patent Office (the “EPO”) that revoked EP2801355 (the “’355 Mon, 07 May 2018 16:30:12 -0400 Forward Pharma A/S News Releases 7111 Forward Pharma Reports Full-Year 2017 Financial and Operational Results http://ir.forward-pharma.com/news-releases/news-release-details/forward-pharma-reports-full-year-2017-financial-and-operational COPENHAGEN, Denmark , April 30, 2018 (GLOBE NEWSWIRE) -- Forward Pharma A/S (Nasdaq:FWP) (“We” or “Forward” or the “Company”), today reported financial results for the year ended December 31, 2017 . Net income for the year ended December 31, 2017 was $917.1 million , or $2.30 per diluted share, Mon, 30 Apr 2018 16:40:28 -0400 Forward Pharma A/S News Releases 7106 Forward Pharma to Present at the 7th Annual Leerink Partners Global Healthcare Conference http://ir.forward-pharma.com/news-releases/news-release-details/forward-pharma-present-7th-annual-leerink-partners-global COPENHAGEN, Denmark , Feb. 07, 2018 (GLOBE NEWSWIRE) -- Forward Pharma A/S (NASDAQ:FWP) (the “Company”) today announced that Dr. Claus Bo Svendsen , the Company’s Chief Executive Officer, will give a corporate update at the 7th Annual Leerink Partners Global Healthcare Conference in New York, NY . Wed, 07 Feb 2018 07:30:45 -0500 Forward Pharma A/S News Releases 7101